Download FREE Report Sample
Download Free sampleRecombinant FSH is produced through recombinant DNA technology.?These products are pure and do not contain the "contaminants" seen in urine extraction FSH.?It is given subcutaneously with much less discomfort.?Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.
Recombinant Follicle Stimulating Hormone Market contains market size and forecasts of Recombinant Follicle Stimulating Hormone in global, including the following market information:
Global Recombinant Follicle Stimulating Hormone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Follicle Stimulating Hormone Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Recombinant Follicle Stimulating Hormone companies in 2021 (%)
The global Recombinant Follicle Stimulating Hormone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
75IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Follicle Stimulating Hormone include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Follicle Stimulating Hormone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Follicle Stimulating Hormone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Follicle Stimulating Hormone Market Segment Percentages, by Type, 2021 (%)
75IU
150IU
Others
Global Recombinant Follicle Stimulating Hormone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Follicle Stimulating Hormone Market Segment Percentages, by Application, 2021 (%)
Infertility Treatment
Assisted Reproductive Technology
Global Recombinant Follicle Stimulating Hormone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Follicle Stimulating Hormone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Follicle Stimulating Hormone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Follicle Stimulating Hormone revenues share in global market, 2021 (%)
Key companies Recombinant Follicle Stimulating Hormone sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Recombinant Follicle Stimulating Hormone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
